Impact BioMedical
IBO • XASE
Impact BioMedical is a pharmaceutical preparations company trading on XASE, led by CEO Frank D. Heuszel, with a market cap of $76.6M.
Market Cap$76.6M
Employees5.0
CEOFrank D. Heuszel
CountryUnited States of America
PHARMACEUTICAL PREPARATIONS
Next EarningsMay 13, 2026 · in a monthQ1 2026
Financials
IBO
Impact BioMedical FAQ
Common questions about Impact BioMedical
Impact BioMedical is scheduled to report earnings for Q1 2026 on May 13, 2026.
Impact BioMedical has approximately 5 employees.